Lv7
4039 积分 2020-04-21 加入
抗血管生成药物在食管胃结合部腺癌及胃癌治疗中的研究进展
1个月前
已完结
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
1个月前
已完结
A perspective on improving the R-CHOP regimen: from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise
1个月前
已完结
Real-world treatment patterns and clinical outcomes of patients with treatment-naïve and relapsed/refractory diffuse large B-cell lymphoma in the United States
1个月前
已完结
A Combination Therapy of Cyclophosphamide and Immunomodulating Agents in Cancer
1个月前
已完结
Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the upfront therapy of transplant ineligible patients with multiple myeloma
1个月前
已完结
Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision
1个月前
已完结
A Combination Therapy of Cyclophosphamide and Immunomodulating Agents in Cancer
1个月前
已完结
Acute graft-versus-host disease
1个月前
已完结
Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy
1个月前
已完结
皖公网安备34019202002308
